Schedule 13G ownership disclosure
Immune Therapeutics Inc
Security class unavailable · CUSIP: 45252A107
Event date: 2019-11-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-19-025701
- Form type
- SC 13G
- Filer
- Ahmetaj Erjon
- CIK
- CIK 1795893
- Filed
- Dec 10, 2019
- Reporting period
- Nov 19, 2019
- Description
- Schedule 13G beneficial ownership